◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
COSMOS Pharmaceutical Corporation (3349) EPS 2022–2025
DATA UPDATED 2026-08-10
COSMOS Pharmaceutical Corporation annual earnings per share (EPS) for fiscal 2024 was JPY 308.61, an increase of 2.7% from JPY 300.48 in fiscal 2023. All figures are reported results from public filings — no estimates or projections.
3349 Annual EPS
| EPS (annual) | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|
| Diluted EPS | — | JPY 309M | JPY 300M | JPY 292M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
More 3349 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow
All 3349 financial statements → Interactive 3349 charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.